Tanya Golubchik Selected Research

P-2 (P 2)

10/2021

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tanya Golubchik Research Topics

Disease

7	Infections 02/2024 - 04/2017
4	COVID-19 01/2022 - 01/2021
2	Fever (Fevers) 12/2022 - 10/2021
2	Tuberculosis (Tuberculoses) 10/2018 - 01/2011
1	Persistent Infection 02/2024
1	Hepatitis B 10/2023
1	Smallpox (Variola) 01/2023
1	Mpox (monkeypox) 01/2023
1	Respiratory Sounds (Crackle) 12/2022
1	Respiratory Syncytial Virus Infections 12/2022
1	Dyspnea (Shortness of Breath) 10/2021
1	Cough 10/2021
1	Ageusia (Hypogeusia) 10/2021
1	Anosmia 10/2021
1	Abscess 12/2017
1	Cross Infection (Nosocomial Infection) 04/2017
1	Sepsis (Septicemia) 03/2012

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 10/2018
3	VaccinesIBA 01/2022 - 10/2021
2	ChAdOx1 nCoV-19IBA 10/2021 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 01/2011
1	Blood Group Antigens (Blood Groups)IBA 02/2024
1	Anti-Idiotypic AntibodiesIBA 02/2024
1	Viral RNAIBA 02/2024
1	RNA (Ribonucleic Acid)IBA 02/2024
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023
1	P-2 (P 2)IBA 10/2021
1	Nucleic AcidsIBA 10/2021
1	MenACWYIBA 10/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 12/2017
1	Antimicrobial PeptidesIBA 12/2017
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2017
1	FluoroquinolonesIBA 04/2017
1	Methicillin (Metin)FDA Link 03/2012

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2022
1	Art Therapy 12/2023
1	Critical Care (Surgical Intensive Care) 12/2022